Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

9.9K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
The Ras Gene02:38

The Ras Gene

6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DDI-MMAF: Multi-modal affine fusion of visual and semantic representations for anticancer drug synergy prediction.

European journal of medicinal chemistry·2026
Same author

Single-Cell and Multiomics Characterization of p21 in Cancer Progression and Therapeutic Sensitivity.

Human mutation·2026
Same author

Integrating Multi-View Residue Graph and Protein Language Model for Cell-Penetrating Peptide Prediction via Global-Local Graph Aggregation and Cross-Attentive Fusion.

IEEE journal of biomedical and health informatics·2026
Same author

The <i>AtFLC</i>-<i>AtFT</i> Pathway Is Involved in the Early Flowering Promoted by Loss of <i>AtHO1</i> Function in <i>Arabidopsis</i>.

Current issues in molecular biology·2026
Same author

An Interpretable Deep Learning Framework Leveraging RNA Foundation Model and Capsule Networks for Accurate Prediction of RNA 2'-O-Methylation Sites.

Journal of chemical information and modeling·2026
Same author

Correction: The multifaceted functions of selective autophagy in cancer: molecular basis, consequences, and clinical prospects.

Molecular cancer·2026

Related Experiment Video

Updated: Jun 29, 2025

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

10.4K

KinPred-RNA-kinase activity inference and cancer type classification using machine learning on RNA-seq data.

Yuntian Zhang1,2, Lantian Yao3,4, Chia-Ru Chung5

  • 1Warshel Institute for Computational Biology, The Chinese University of Hong Kong, Shenzhen 518172, China.

Iscience
|March 25, 2024
PubMed
Summary

This study introduces KinPred-RNA, a new computational method to determine kinase activity from RNA sequencing data in cancer. This approach offers a cost-effective way to identify potential cancer drivers.

Keywords:
CancerMachine learning

More Related Videos

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.7K
Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis
07:29

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Published on: May 16, 2020

6.1K

Related Experiment Videos

Last Updated: Jun 29, 2025

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

10.4K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.7K
Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis
07:29

Characterization of In Vitro Differentiation of Human Primary Keratinocytes by RNA-Seq Analysis

Published on: May 16, 2020

6.1K

Area of Science:

  • Biochemistry
  • Bioinformatics
  • Oncology

Background:

  • Kinases are crucial enzymes regulating cellular processes through phosphorylation.
  • Current methods for assessing kinase activity, often based on phosphoproteomics, are sample-intensive and costly.
  • There is a need for methods to infer kinase activity directly from RNA sequencing data, especially in cancer research.

Purpose of the Study:

  • To develop a computational framework, KinPred-RNA, for deriving kinase activities from bulk RNA sequencing data.
  • To enable the analysis of kinase activity in cancer samples without the need for expensive phosphoproteomics.
  • To provide a novel tool for cancer research and potentially identify novel cancer drivers.

Main Methods:

  • Developed the KinPred-RNA computational framework utilizing the extreme gradient boosting (XGBoost) regression model.
  • Employed efficient gene signatures derived from the LINCS-L1000 dataset as input features for the model.
  • Compared the performance of XGBoost against other regression models, including random forest, multiple linear regression, and support vector machine regression.

Main Results:

  • The KinPred-RNA framework, powered by XGBoost, demonstrated superior performance in predicting kinase activities from cancer RNA sequencing data compared to alternative regression models.
  • The identified gene signatures showed potential relevance to biological functions, underscoring the biological interpretability of the model.
  • The study successfully established a method to derive kinase activities from readily available RNA sequencing data.

Conclusions:

  • KinPred-RNA represents a significant advancement in computational oncology, offering a novel approach to assess kinase activity from RNA sequencing data.
  • This framework has the potential to facilitate the identification of key kinases involved in cancer development and progression.
  • KinPred-RNA provides a valuable, cost-effective tool for cancer research, potentially accelerating the discovery of therapeutic targets.